Evidence map›Paper›PMID 23452680›Full record

Trial reportJournal of the American Academy of Child and Adolescent Psychiatry2013

N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.

Michael H Bloch, Kaitlyn E Panza, Jon E Grant, Christopher Pittenger, James F Leckman

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Academy of Child and Adolescent Psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 8 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 8 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pharmacotherapy for trichotillomania.The Cochrane database of systematic reviews · 2021
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. The Potential ofInternational journal of environmental research and public health · 2022
    Review
  17. Review
  18. Article
  19. Trichotillomania and Skin-Picking Disorder: An Update.Focus (American Psychiatric Publishing) · 2021
    Article
  20. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.Journal of child and adolescent psychopharmacology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael H BlochChild Study Center, Yale University School of Medicine, New Haven, CT 06520, USA. michael.bloch@yale.edu
Kaitlyn E Panza
Jon E Grant
Christopher Pittenger
James F Leckman
Yale University · USUniversity of Chicago · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
TRAINING PROGRAM IN CHILDHOOD NEUROPSYCHIATRIC DISORDERST32MH018268 · NIMH · YALE UNIVERSITY · PI Michael H Bloch, MICHAEL J CROWLEY · 1985 to 2026
$11.0M
Research Training for Medical Students & Physician-Scientists in Child PsychiatryR25MH077823 · NIMH · YALE UNIVERSITY · PI ANDRES S MARTIN · 2006 to 2026
$4.0M
Longitudinal Structural MRI Study of Adulthood Outcome in Tourette SyndromeK23MH091240 · NIMH · YALE UNIVERSITY · PI BLOCH, MICHAEL H · 2010 to 2014
$902k
CREB and the molecular underpinnings of habit learningK08MH081190 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2008 to 2012
$897k
NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1RR024139NIMH NIH HHS K08 MH081190NIMH NIH HHS K08MH081190NIMH NIH HHS K23 MH091240NIMH NIH HHS K23MH091240NIMH NIH HHS R25 MH077823NIMH NIH HHS T32 MH018268NIMH NIH HHS T32MH018268-26
6 · The paper itself

Abstract

objectiveTo examine the efficacy of N-acetylcysteine (NAC) for the treatment of pediatric trichotillomania (TTM) in a double-blind, placebo-controlled, add-on study.

methodA total of 39 children and adolescents aged 8 to 17 years with pediatric trichotillomania were randomly assigned to receive NAC or matching placebo for 12 weeks. Our primary outcome was change in severity of hairpulling as measured by the Massachusetts General Hospital-Hairpulling Scale (MGH-HPS). Secondary measures assessed hairpulling severity, automatic versus focused pulling, clinician-rated improvement, and comorbid anxiety and depression. Outcomes were examined using linear mixed models to test the treatment×time interaction in an intention-to-treat population.

resultsNo significant difference between N-acetylcysteine and placebo was found on any of the primary or secondary outcome measures. On several measures of hairpulling, subjects significantly improved with time regardless of treatment assignment. In the NAC group, 25% of subjects were judged as treatment responders, compared to 21% in the placebo group.

conclusionsWe observed no benefit of NAC for the treatment of children with trichotillomania. Our findings stand in contrast to a previous, similarly designed trial in adults with TTM, which demonstrated a very large, statistically significant benefit of NAC. Based on the differing results of NAC in pediatric and adult TTM populations, the assumption that pharmacological interventions demonstrated to be effective in adults with TTM will be as effective in children, may be inaccurate. This trial highlights the importance of referring children with TTM to appropriate behavioral therapy before initiating pharmacological interventions, as behavioral therapy has demonstrated efficacy in both children and adults with trichotillomania.

Indexed as

AcetylcysteineAdolescentChildDouble-Blind MethodFemaleFree Radical ScavengersHumansMalePlacebosPsychiatric Status Rating ScalesSeverity of Illness IndexTreatment OutcomeTrichotillomaniaAcetylcysteineFree Radical ScavengersPlacebos

Identifiers

PMID23452680
PMCPMC3745012
OpenAlexW2156816749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.